2024 Q1 Form 10-K Financial Statement

#000165495424004048 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $1.587M $1.265M $5.240M
YoY Change 17.4% 12.56% 136.06%
Cost Of Revenue $582.6K $428.6K $1.997M
YoY Change -4.27% 15.32% 95.54%
Gross Profit $1.004M $836.3K $3.243M
YoY Change 35.13% 11.19% 170.58%
Gross Profit Margin 63.29% 66.12% 61.89%
Selling, General & Admin $1.338M $1.633M $7.201M
YoY Change -21.13% 18.36% 68.57%
% of Gross Profit 133.21% 195.24% 222.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $277.9K $189.8K $739.8K
YoY Change 62.51% 52.03% 492.63%
% of Gross Profit 27.67% 22.69% 22.81%
Operating Expenses $1.612M $1.633M $7.201M
YoY Change -23.01% 18.36% 35.62%
Operating Profit -$608.1K -$796.5K -$3.958M
YoY Change -55.0% 26.95% -3.72%
Interest Expense -$22.87K $4.320K $89.84K
YoY Change -135.57% -61.15% 153.21%
% of Operating Profit
Other Income/Expense, Net -$22.45K $0.00 $2.940K
YoY Change -133.46% -100.0% -102.39%
Pretax Income -$630.5K -$833.5K -$8.145M
YoY Change -50.9% -33.4% 92.35%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$630.5K -$905.3K -$8.372M
YoY Change -50.9% -30.85% 97.72%
Net Earnings / Revenue -39.73% -71.57% -159.77%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.14 -$0.18 -$1.64
COMMON SHARES
Basic Shares Outstanding 0.000 shares 5.110M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $529.8K $982.3K $982.3K
YoY Change -88.64% -85.34% -85.34%
Cash & Equivalents $529.8K $982.3K
Short-Term Investments
Other Short-Term Assets $192.4K $111.1K $111.1K
YoY Change -20.31% -47.64% -47.64%
Inventory $92.52K $92.64K $92.64K
Prepaid Expenses
Receivables $123.8K $90.07K $90.07K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $938.5K $1.276M $1.276M
YoY Change -81.64% -82.17% -82.17%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $3.096M $1.167M
YoY Change -26.63% -72.27%
Intangibles $4.060M $3.110M
YoY Change -10.89% -19.52%
Long-Term Investments $267.9K $427.1K $427.1K
YoY Change -3.93% -1.68% -1.68%
Other Assets $147.4K $151.0K $151.0K
YoY Change 15.3% 35.13% 35.13%
Total Long-Term Assets $7.735M $4.855M $4.855M
YoY Change -17.15% -43.67% -43.67%
TOTAL ASSETS
Total Short-Term Assets $938.5K $1.276M $1.276M
Total Long-Term Assets $7.735M $4.855M $4.855M
Total Assets $8.674M $6.131M $6.131M
YoY Change -39.96% -61.13% -61.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $460.4K $493.8K $493.8K
YoY Change 34.36% -10.29% -10.29%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Long-Term Debt Due $791.6K $17.32K $17.32K
YoY Change -67.24% -99.29% -99.29%
Total Short-Term Liabilities $2.754M $789.1K $789.1K
YoY Change -10.69% -76.11% -76.11%
LONG-TERM LIABILITIES
Long-Term Debt $690.0K $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $690.0K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.754M $789.1K $789.1K
Total Long-Term Liabilities $690.0K $0.00 $0.00
Total Liabilities $3.444M $789.1K $789.1K
YoY Change 11.69% -76.11% -76.11%
SHAREHOLDERS EQUITY
Retained Earnings -$16.66M -$15.95M
YoY Change 86.91% 110.44%
Common Stock $5.108K $413.2K
YoY Change -98.78% -1.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.230M $5.342M $5.342M
YoY Change
Total Liabilities & Shareholders Equity $8.674M $6.131M $6.131M
YoY Change -39.96% -61.13% -61.13%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$630.5K -$905.3K -$8.372M
YoY Change -50.9% -30.85% 97.72%
Depreciation, Depletion And Amortization $277.9K $189.8K $739.8K
YoY Change 62.51% 52.03% 492.63%
Cash From Operating Activities -$431.0K -$591.8K -$2.752M
YoY Change -57.83% 19.02% -4.15%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions $240.0K $850.0K
YoY Change -71.76% -80.05%
Other Investing Activities -$250.0K $0.00 -$850.0K
YoY Change -70.59% -100.0% -80.16%
Cash From Investing Activities -$250.0K $0.00 -$850.0K
YoY Change -70.59% -100.0% -80.16%
FINANCING ACTIVITIES
Cash Dividend Paid $70.12K $213.7K
YoY Change -6.5% 50.23%
Common Stock Issuance & Retirement, Net $565.0K
YoY Change -95.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $264.1K -1.887M -2.157M
YoY Change -295.18% 1191.25% -117.81%
NET CHANGE
Cash From Operating Activities -$431.0K -591.8K -2.752M
Cash From Investing Activities -$250.0K 0.000 -850.0K
Cash From Financing Activities $264.1K -1.887M -2.157M
Net Change In Cash -$452.5K -2.478M -5.758M
YoY Change -77.79% -49.93% -215.38%
FREE CASH FLOW
Cash From Operating Activities -$431.0K -$591.8K -$2.752M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001825452
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
0 shares
CY2023Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5107395 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5107395 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5107395 shares
CY2022 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.1 pure
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41466
CY2023 dei Entity Registrant Name
EntityRegistrantName
ONFOLIO HOLDINGS INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1978697
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1007 North Orange Street, 4th Floor
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19801
CY2023 dei City Area Code
CityAreaCode
682
CY2023 dei Local Phone Number
LocalPhoneNumber
990-6920
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2023 dei Trading Symbol
TradingSymbol
ONFO
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
982261 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6701122 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
90070 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
137598 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
92637 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
105129 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
111097 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
212180 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1276065 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
7156029 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3110204 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3864618 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1167194 usd
CY2022Q4 us-gaap Goodwill
Goodwill
4209126 usd
CY2023Q4 onfo Due From Related Party
DueFromRelatedParty
150974 usd
CY2022Q4 onfo Due From Related Party
DueFromRelatedParty
111720 usd
CY2023Q4 onfo Total Cost Method Investments
TotalCostMethodInvestments
154007 usd
CY2022Q4 onfo Total Cost Method Investments
TotalCostMethodInvestments
154007 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
273042 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
280326 usd
CY2023Q4 us-gaap Assets
Assets
6131483 usd
CY2022Q4 us-gaap Assets
Assets
15775826 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
493816 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
550454 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
68011 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
54404 usd
CY2023Q4 onfo Acquisition Notes Payable Current
AcquisitionNotesPayableCurrent
17323 usd
CY2022Q4 onfo Acquisition Notes Payable Current
AcquisitionNotesPayableCurrent
2456323 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
68959 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
60000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
60000 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
149965 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
113251 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
789115 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3303391 usd
CY2023Q4 us-gaap Liabilities
Liabilities
789115 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3303391 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
93 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
70 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5107395 shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21107311 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19950774 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
182465 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
96971 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15952609 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7580490 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
5342368 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
12472435 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6131483 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15775826 usd
CY2023 onfo Revenue Services
RevenueServices
1496038 usd
CY2022 onfo Revenue Services
RevenueServices
544822 usd
CY2023 onfo Revenue Product Sales
RevenueProductSales
3743948 usd
CY2022 onfo Revenue Product Sales
RevenueProductSales
1674993 usd
CY2023 us-gaap Revenues
Revenues
5239986 usd
CY2022 us-gaap Revenues
Revenues
2219815 usd
CY2023 onfo Cost Of Revenue Services
CostOfRevenueServices
837888 usd
CY2022 onfo Cost Of Revenue Services
CostOfRevenueServices
356957 usd
CY2023 onfo Cost Of Revenue Product Sales
CostOfRevenueProductSales
1159267 usd
CY2022 onfo Cost Of Revenue Product Sales
CostOfRevenueProductSales
664405 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
1997155 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
1021362 usd
CY2023 us-gaap Gross Profit
GrossProfit
3242831 usd
CY2022 us-gaap Gross Profit
GrossProfit
1198453 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6040688 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4271865 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
1160410 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
509941 usd
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
3952433 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023 us-gaap Acquisition Costs
AcquisitionCosts
326899 usd
CY2022 us-gaap Acquisition Costs
AcquisitionCosts
527792 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
11480430 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
5309598 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-8237599 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-4111145 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
13190 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34432 usd
CY2023 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1610 usd
CY2022 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
3193 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
75041 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2152 usd
CY2023 us-gaap Other Income
OtherIncome
2937 usd
CY2022 us-gaap Other Income
OtherIncome
13223 usd
CY2023 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 usd
CY2022 us-gaap Impairment Of Investments
ImpairmentOfInvestments
137602 usd
CY2023 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
CY2022 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-34306 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
92778 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-123212 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8144821 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4234357 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8144821 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4234357 usd
CY2023 us-gaap Dividends Preferred Stock
DividendsPreferredStock
227298 usd
CY2022 us-gaap Dividends Preferred Stock
DividendsPreferredStock
195145 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8372119 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4429502 usd
CY2023 onfo Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-1.64
CY2022 onfo Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-1.35
CY2023 onfo Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
5107395 shares
CY2022 onfo Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
3285934 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3373804 usd
CY2022 onfo Preferred Shares For Cash Amount
PreferredSharesForCashAmount
321500 usd
CY2022 onfo Common Stock Sold For Cash Amount
CommonStockSoldForCashAmount
12104667 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
944995 usd
CY2022 onfo Warrants Issued For Acquisition
WarrantsIssuedForAcquisition
60000 usd
CY2022 onfo Preferred Dividends
PreferredDividends
-195145 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
96971 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4234357 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
12472435 usd
CY2023 onfo Preferred Shares For Cash Amount
PreferredSharesForCashAmount
565000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
591558 usd
CY2023 onfo Preferred Dividends
PreferredDividends
-227298 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
85494 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8144821 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
5342368 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8144821 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4234357 usd
CY2023 onfo Ividends Received From Equity Method Investment
ividendsReceivedFromEquityMethodInvestment
20474 usd
CY2022 onfo Ividends Received From Equity Method Investment
ividendsReceivedFromEquityMethodInvestment
33488 usd
CY2023 onfo Impairment Of Cost Method Investment
ImpairmentOfCostMethodInvestment
0 usd
CY2022 onfo Impairment Of Cost Method Investment
ImpairmentOfCostMethodInvestment
51894 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-34306 usd
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
3952433 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023 us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
0 usd
CY2022 us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
45694 usd
CY2023 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0 usd
CY2022 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
67500 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12104667 usd
CY2023 onfo Payment Of Contribution To Joint Venture Note Payable
PaymentOfContributionToJointVentureNotePayable
0 usd
CY2022 onfo Payment Of Contribution To Joint Venture Note Payable
PaymentOfContributionToJointVentureNotePayable
215000 usd
CY2023 onfo Payments On Acquisition Note Payable
PaymentsOnAcquisitionNotePayable
2439000 usd
CY2022 onfo Payments On Acquisition Note Payable
PaymentsOnAcquisitionNotePayable
0 usd
CY2023 onfo Notes Payable Issued For Asset Acquisitions
NotesPayableIssuedForAssetAcquisitions
0 usd
CY2022 onfo Notes Payable Issued For Asset Acquisitions
NotesPayableIssuedForAssetAcquisitions
2439000 usd
CY2022 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
0 usd
CY2023 us-gaap Revenues
Revenues
5239986 usd
CY2022 us-gaap Revenues
Revenues
2219815 usd
CY2023 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.10 pure
CY2023 us-gaap Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
0.50 pure
CY2023 us-gaap Investment Company Total Return Payment To Fund By Affiliate
InvestmentCompanyTotalReturnPaymentToFundByAffiliate
0.358 pure
CY2023 us-gaap Management Fee Expense
ManagementFeeExpense
125577 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
296211 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
1370461 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
248611 usd
CY2023 us-gaap Production Costs
ProductionCosts
661538 usd
CY2022 us-gaap Production Costs
ProductionCosts
609776 usd
CY2023 us-gaap Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
3082410 usd
CY2022 us-gaap Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
1065217 usd
CY2023 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
0 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Beat Percent
EffectiveIncomeTaxRateReconciliationBeatPercent
0.50 pure
CY2023 onfo Purchase Price Paid
PurchasePricePaid
850000 usd
CY2023 onfo Goodwill Impairments Loss
GoodwillImpairmentsLoss
580284 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
397804 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3989450 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3110204 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3864618 usd
CY2022Q2 onfo Selling Intellectual Property
SellingIntellectualProperty
45694 usd
CY2022Q2 us-gaap Disposal Group Deferred Gain On Disposal
DisposalGroupDeferredGainOnDisposal
34306 usd
CY2023 us-gaap Finite Lived Intangible Assets Cost Incurred To Renew Or Extend
FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend
7392 usd
CY2022Q4 us-gaap Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income
BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome
512000 usd
CY2022Q4 us-gaap Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income
BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome
1443000 usd
CY2022Q4 us-gaap Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income
BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome
692000 usd
CY2023Q1 us-gaap Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income
BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome
850000 usd
CY2023Q1 onfo Finite Lived Intangible Assets Remaining Amortization Period
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod
P4Y
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
889937 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
756419 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
745955 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
635746 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
204270 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
167171 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
182320 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2691881 usd
CY2023 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
22600 shares
CY2022 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
12860 shares
CY2023 us-gaap Dividends
Dividends
227298 usd
CY2022 us-gaap Dividends
Dividends
195145 usd
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
213691 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
142239 usd
CY2023Q4 onfo Unpaid Dividends
UnpaidDividends
68011 usd
CY2022Q4 onfo Unpaid Dividends
UnpaidDividends
54404 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 onfo Warrant Exercise Price
WarrantExercisePrice
5.00
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
413063 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
826126 usd
CY2023 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
0.15 pure
CY2023 onfo Description Of Additional Warrants
DescriptionOfAdditionalWarrants
On August 29, 2022, the underwriter partially exercised this option and purchased 609,750 additional warrants at the purchase price of $.01 per warrant for aggregate gross proceeds of $6,097.50
CY2023 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
82613 usd
CY2023 onfo Warrant Exercise Price
WarrantExercisePrice
5.50
CY2023 us-gaap Public Utilities Interim Rate Increase Decrease Percentage
PublicUtilitiesInterimRateIncreaseDecreasePercentage
1.10 pure
CY2023 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
2753750 shares
CY2023 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
5507500 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
13774848 usd
CY2022Q3 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
12225470 usd
CY2020Q4 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3233336 usd
CY2023 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
447248 usd
CY2022 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
766656 usd
CY2023Q4 onfo Purchase Of Common Stock
PurchaseOfCommonStock
60000 shares
CY2023 onfo Description Of Black Scholes Option Pricing Model
DescriptionOfBlackScholesOptionPricingModel
the Company, of which 30,000 vested immediately, and 2,500 per quarter thereafter until fully vested. One consultant was awarded 36,000 options that vest monthly over a one year period. The fair value of the stock options was estimate using a black-Scholes option pricing model and the following assumptions: 1) dividend yield of 0%; 2) risk-free rate of between 3.70% and 4.22%; 3) volatility of between 90.14% and 92.85% based on a group of peer group companies; and an expected term of five to ten years
CY2023 us-gaap Key Provisions Of Operating Or Partnership Agreement Description
KeyProvisionsOfOperatingOrPartnershipAgreementDescription
During the year ended December 31, 2022, the Company issued a total of 49,560 options to certain employees of the Company with an exercise price of $5.95, and an exercise term of three years. The Company estimated fair value of these options to be $4.41 per share using a Black-Scholes option pricing model, and the expense associated with the options will be recognized over the requite service period of 20 months
CY2023 us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
23100 shares
CY2022 onfo Description Of Black Scholes Option Pricing Model
DescriptionOfBlackScholesOptionPricingModel
1) dividend yield of 0%; 2) risk-free rate of 0.97% to 1.91%; 3) volatility of 127.7% to 129.5% based on a group of peer group companies; 4) a common stock price of $5.95 based on the most recent common stock sales for cash, and 5) an expected term of three years
CY2023Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
124310 usd
CY2022Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
121672 usd
CY2023 us-gaap Officers Compensation
OfficersCompensation
30249 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1
NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1
P3Y7M20D
CY2023Q4 onfo Due From Related Parties Included In Current Assets
DueFromRelatedPartiesIncludedInCurrentAssets
93372 usd
CY2022Q4 onfo Due From Related Parties Included In Current Assets
DueFromRelatedPartiesIncludedInCurrentAssets
54858 usd
CY2022Q4 onfo Paid To Related Party
PaidToRelatedParty
215000 usd
CY2023Q4 onfo Due To Related Parties Included In Current Liabilities
DueToRelatedPartiesIncludedInCurrentLiabilities
36994 usd
CY2022Q4 onfo Due To Related Parties Included In Current Liabilities
DueToRelatedPartiesIncludedInCurrentLiabilities
36854 usd
CY2022Q2 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
47520 usd
CY2022Q2 us-gaap Proceeds From Customers
ProceedsFromCustomers
44000 usd
CY2022Q2 us-gaap Public Utilities Approved Rate Increase Decrease Percentage
PublicUtilitiesApprovedRateIncreaseDecreasePercentage
0.17 pure
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
82490 usd
CY2022Q4 us-gaap Proceeds From Customers
ProceedsFromCustomers
73000 usd
CY2022Q4 us-gaap Public Utilities Approved Rate Increase Decrease Percentage
PublicUtilitiesApprovedRateIncreaseDecreasePercentage
0.17 pure
CY2023Q4 onfo Company Owed
CompanyOwed
0 usd
CY2022Q4 onfo Company Owed
CompanyOwed
68959 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1710412 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-889215 usd
CY2023 onfo Permanent Differences
PermanentDifferences
1109592 usd
CY2022 onfo Permanent Differences
PermanentDifferences
235561 usd
CY2023 onfo Operating Loss Carryforwards1
OperatingLossCarryforwards1
600821 usd
CY2022 onfo Operating Loss Carryforwards1
OperatingLossCarryforwards1
653654 usd
CY2023 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
0 usd
CY2022 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
0 usd
CY2023 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2022 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2023 onfo Provision For Income Taxes Current
ProvisionForIncomeTaxesCurrent
0 usd
CY2022 onfo Provision For Income Taxes Current
ProvisionForIncomeTaxesCurrent
0 usd
CY2023 onfo Temporary Equity Other Changes1
TemporaryEquityOtherChanges1
0 usd
CY2022 onfo Temporary Equity Other Changes1
TemporaryEquityOtherChanges1
0 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1254474 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
918400 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1254474 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
918400 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 usd

Files In Submission

Name View Source Status
0001654954-24-004048-index-headers.html Edgar Link pending
0001654954-24-004048-index.html Edgar Link pending
0001654954-24-004048.txt Edgar Link pending
0001654954-24-004048-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
onfo-20231231.xsd Edgar Link pending
onfolio_10k.htm Edgar Link pending
onfolio_10kimg3.jpg Edgar Link pending
onfolio_ex1010.htm Edgar Link pending
onfolio_ex1017.htm Edgar Link pending
onfolio_ex1017img1.jpg Edgar Link pending
onfolio_ex1017img2.jpg Edgar Link pending
onfolio_ex1017img3.jpg Edgar Link pending
onfolio_ex1017img4.jpg Edgar Link pending
onfolio_ex1017img5.jpg Edgar Link pending
onfolio_ex1017img6.jpg Edgar Link pending
onfolio_ex1017img7.jpg Edgar Link pending
onfolio_ex1017img8.jpg Edgar Link pending
onfolio_ex1017img9.jpg Edgar Link pending
onfolio_ex211.htm Edgar Link pending
onfolio_ex221.htm Edgar Link pending
onfolio_ex231.htm Edgar Link pending
onfolio_ex311.htm Edgar Link pending
onfolio_ex312.htm Edgar Link pending
onfolio_ex321.htm Edgar Link pending
onfolio_ex322.htm Edgar Link pending
onfolio_ex46.htm Edgar Link pending
onfo-20231231_cal.xml Edgar Link unprocessable
onfo-20231231_def.xml Edgar Link unprocessable
onfo-20231231_lab.xml Edgar Link unprocessable
onfo-20231231_pre.xml Edgar Link unprocessable
onfolio_10k_htm.xml Edgar Link completed
onfolio_ex971.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable